These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3661161)

  • 21. Distribution of G1m(1), G1m(2) and G3m(5) allotypes in Aragon.
    Almuzara I; Martinez Jarreta B; Castellano M
    Hum Hered; 1991; 41(6):409-10. PubMed ID: 1797636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gm and Km allotypes and typhoid fever.
    Herrera P; Arcos-Burgos M; Valenzuela CY; Pandey JP
    Exp Clin Immunogenet; 1996; 13(3-4):121-5. PubMed ID: 9165265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GM and KM allotypes in eight tribal populations of Madyha Pradesh and Orissa, India.
    Walter H; Matsumoto H; Danker-Hopfe H; Malhotra KC; Mukherjee BN
    Jpn J Hum Genet; 1997 Mar; 42(1):193-203. PubMed ID: 9183999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between Km1 immunoglobulin allotype and pulmonary tuberculosis in Indonesians.
    Gibson J; Grange J; Beck JS; Kardjito T
    Exp Clin Immunogenet; 1987; 4(3):129-35. PubMed ID: 3152540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin allotypes and IgG subclass antibody response to Aspergillus fumigatus in cystic fibrosis patients.
    Skov M; Pandey JP; Pressler T; Høiby N; Koch C
    J Cyst Fibros; 2004 Aug; 3(3):173-8. PubMed ID: 15463904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies against IgG allotypes G1m(z), G1m(a), G1m(f), G3m(b1/u) and G3m(g1): their usefulness in HAI and capture ELISA.
    de Lange GG; van Leeuwen AM; Vlug A; van Eede PH; Engelfriet CP; Lincoln PJ
    Exp Clin Immunogenet; 1989; 6(1):18-30. PubMed ID: 2629885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An improved method for the production of antisera to G1m allotypes.
    Kishida T; Tamaki Y
    Jinrui Idengaku Zasshi; 1983 Dec; 28(4):269-72. PubMed ID: 6678315
    [No Abstract]   [Full Text] [Related]  

  • 28. Distribution of nominal and latent IgG (Gm) allotypes in plaques of multiple sclerosis brain.
    Salier JP; Glynn P; Goust JM; Cuzner ML
    Clin Exp Immunol; 1983 Dec; 54(3):634-40. PubMed ID: 6606512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gm and Km allotypes in a Chilean urban population sample].
    Arcos-Burgos M; Valenzuela CY; Herrera PJ; Pandey JP
    Rev Med Chil; 1997 Feb; 125(2):161-4. PubMed ID: 9430935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunogenetics of myasthenia gravis. Significance of HLA-, complement and Cm gene systems for clinical and immunologic parameters].
    Grosse-Wilde H; Toyka KV; Besinger UA; Doxiadis I; Heininger K; Hömberg M; Hömberg V; Hohlfeld R; Fateh-Moghadam A; Jungwirth J; Kreeb G; Vögeler U
    Dtsch Med Wochenschr; 1983 May; 108(18):694-700. PubMed ID: 6839994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 oncoprotein overexpression correlates with mutagen-induced chromosome fragility in head and neck cancer patients with multiple malignancies.
    Gallo O; Bianchi S; Giovannucci-Uzzielli ML; Santoro R; Lenzi S; Salimbeni C; Abbruzzese M; Alajmo E
    Br J Cancer; 1995 May; 71(5):1008-12. PubMed ID: 7734291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin G subclasses.
    Moss RB
    West J Med; 1991 Apr; 154(4):458. PubMed ID: 1877188
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis.
    Pandey JP; Goust JM; Salier JP; Fudenberg HH
    J Clin Invest; 1981 Jun; 67(6):1797-1800. PubMed ID: 6787085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gm and Km allotypes in autoimmune diseases.
    Dugoujon JM; Guitard E; Senegas MT
    G Ital Cardiol; 1992 Jan; 22(1):85-95. PubMed ID: 1624073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.
    Pressler T; Pandey JP; Espersen F; Pedersen SS; Fomsgaard A; Koch C; Høiby N
    Clin Exp Immunol; 1992 Nov; 90(2):209-14. PubMed ID: 1424275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of Gm and Km allotypes among five populations in China.
    Matsumoto H; Miyazaki T; Xu X; Watanabe H; Kawai N; Suzuki K
    Am J Phys Anthropol; 1986 Jun; 70(2):161-5. PubMed ID: 3740244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppressed G2m(n) levels from IGHCG2 in IgA deficiency.
    Oxelius VA
    Exp Clin Immunogenet; 1996; 13(1):1-6. PubMed ID: 8854082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of allotypes on the IgG subclass response to chromosomal beta-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients.
    Ciofu O; Pressler T; Pandey JP; Høiby N
    Clin Exp Immunol; 1997 Apr; 108(1):88-94. PubMed ID: 9097916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin Allotypes of European Populations. I. Gm and Km(Inv) allotypic markers in Hungarians.
    Schanfield MS; Gergely J; Fudenberg HH
    Hum Hered; 1975; 25(5):370-7. PubMed ID: 1222944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin allotypes and virus antibodies in Finnish type 1 diabetic patients.
    Hyöty H; Pandey JP; Lehtinen M; Kulomaa P; Leinikki P
    Exp Clin Immunogenet; 1988; 5(1):52-9. PubMed ID: 2856169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.